Validation of Biosafety and Activity of Albizia antunesiana Lyophilised Leaf Extracts

Albizia antunesiana, from the Fabaceae family is a widespread plant species prevalent in tropical and subtropical regions of Africa. The plant is extensively utilized in traditional medicine for various ailments, particularly in the management of acute and chronic wounds. The use of Albizia antunesiana in traditional medicine has never been scientifically validated for its biosafety and activity. Our current study aimed to validate its biosafety and the pharmacological activity of the plant to ensure therapeutic efficacy while minimizing potential risks. Our investigations qualitatively and quantitatively determined the secondary metabolites of Albizia antunesiana, its activity as an anti-bacterial and anti-inflammatory agent as well as assessing the toxicity profile of the lyophilised leaf extract. The phytoscreening was done using various classical wet chemistry techniques. The biosafety study was based on an amended OECD guideline 425, using Sprague Dawley rat models. The anti-bacterial evaluations were done using a modified Kirby-Bauer test (disk diffusion test) on Pseudomonas aeruginosa, methicillin-sensitive Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae with doxycycline as a standard. The egg albumin test was used to determine the anti-inflammatory potential of the plant. The phytoscreening assays confirmed the presence of numerous biomedically relevant secondary metabolites with high polyphenolic and flavonoid yields. The antibacterial tests demonstrated high antibacterial activity with an MIC of 300mg comparable to 10mg doxycycline and the anti-inflammatory activity at 8000mg/ was comparable to the standard diclofenac at 2000mg. The toxicity tests showed an LD50 above 2500mg/kg body weight. It was therefore concluded that the presence of bioactive secondary metabolites in lyophilized extracts of the aerial parts of Albizia antunesiana possess significant anti-inflammatory and antioxidant profiles. The extracts were also toxicologically safe according to the Hodge and Sterner toxicity scale, thereby supporting their continued use as an adjunct therapy in traditional medical practices in Southern Africa.

Authors

Publication Details

Journal
Journal of Complementary and Alternative Medical Research
Published
2025-07-12
DOI
https://doi.org/10.9734/jocamr/2025/v26i7680
Citations
1
Primary Topic
Psidium guajava Extracts and Applications
Type
article
Field-Weighted Citation Impact
1.56
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation of Biosafety and Activity of Albizia antunesiana Lyophilised Leaf Extracts

Jephat Chifamba, O T CHIKORE, G MANYUCHI
1 citations
Journal of Complementary and Alternative Medical Research
Psidium guajava Extracts and Applications
1.56
article

Validation of Biosafety and Activity of Albizia antunesiana Lyophilised Leaf Extracts

Jephat Chifamba, O T CHIKORE, G MANYUCHI
article en
1 citations

Abstract

Albizia antunesiana, from the Fabaceae family is a widespread plant species prevalent in tropical and subtropical regions of Africa. The plant is extensively utilized in traditional medicine for various ailments, particularly in the management of acute and chronic wounds. The use of Albizia antunesiana in traditional medicine has never been scientifically validated for its biosafety and activity. Our current study aimed to validate its biosafety and the pharmacological activity of the plant to ensure therapeutic efficacy while minimizing potential risks. Our investigations qualitatively and quantitatively determined the secondary metabolites of Albizia antunesiana, its activity as an anti-bacterial and anti-inflammatory agent as well as assessing the toxicity profile of the lyophilised leaf extract. The phytoscreening was done using various classical wet chemistry techniques. The biosafety study was based on an amended OECD guideline 425, using Sprague Dawley rat models. The anti-bacterial evaluations were done using a modified Kirby-Bauer test (disk diffusion test) on Pseudomonas aeruginosa, methicillin-sensitive Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae with doxycycline as a standard. The egg albumin test was used to determine the anti-inflammatory potential of the plant. The phytoscreening assays confirmed the presence of numerous biomedically relevant secondary metabolites with high polyphenolic and flavonoid yields. The antibacterial tests demonstrated high antibacterial activity with an MIC of 300mg comparable to 10mg doxycycline and the anti-inflammatory activity at 8000mg/ was comparable to the standard diclofenac at 2000mg. The toxicity tests showed an LD50 above 2500mg/kg body weight. It was therefore concluded that the presence of bioactive secondary metabolites in lyophilized extracts of the aerial parts of Albizia antunesiana possess significant anti-inflammatory and antioxidant profiles. The extracts were also toxicologically safe according to the Hodge and Sterner toxicity scale, thereby supporting their continued use as an adjunct therapy in traditional medical practices in Southern Africa.

Journal of Complementary and Alternative Medical ResearchVol. 26(7)
Openalex Percentile: Top 17%
Psidium guajava Extracts and Applications
1.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Validation of Biosafety and Activity of Albizia antunesiana Lyophilised Leaf Extracts — Jephat Chifamba, O T CHIKORE, et al. · Journal of Complementary and Alternative Medical Research (2025) | TGRS Research Map | TGRS